Healthcare provider profile · identity verified

Kelly Jo Wolfkill, FNP-BC

Nurse Practitioner · NEWPORT, PA · NPI 1124761986

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	395	114
Lisinopril	Lisinopril	330	94
Levothyroxine Sodium	Levothyroxine Sodium	278	60
Amlodipine Besylate	Amlodipine Besylate	268	68
Pantoprazole Sodium	Pantoprazole Sodium	224	64
Rosuvastatin Calcium	Rosuvastatin Calcium	219	58
Metoprolol Succinate	Metoprolol Succinate	217	62
Albuterol Sulfate Hfa	Albuterol Sulfate	188	54
Gabapentin	Gabapentin	185	53
Metformin Hcl	Metformin Hcl	162	48
Furosemide	Furosemide	154	35
Losartan Potassium	Losartan Potassium	141	35
Sertraline Hcl	Sertraline Hcl	140	31
Tamsulosin Hcl	Tamsulosin Hcl	140	40
Montelukast Sodium	Montelukast Sodium	129	34
Simvastatin	Simvastatin	127	38
Trazodone Hcl	Trazodone Hcl	121	27
Escitalopram Oxalate	Escitalopram Oxalate	120	29
Omeprazole	Omeprazole	120	32
Meloxicam	Meloxicam	93	38
Hydrochlorothiazide	Hydrochlorothiazide	91	24
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	86	12
Doxycycline Hyclate	Doxycycline Hyclate	83	67
Potassium Chloride	Potassium Chloride	82	16
Metoprolol Tartrate	Metoprolol Tartrate	81	24
Clopidogrel	Clopidogrel Bisulfate	80	24
Fenofibrate	Fenofibrate Nanocrystallized	78	24
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	76	15
Eliquis	Apixaban	74	23
Celecoxib	Celecoxib	69	22
Lorazepam	Lorazepam	68	13
Duloxetine Hcl	Duloxetine Hcl	66	22
Famotidine	Famotidine	64	21
Pioglitazone Hcl	Pioglitazone Hcl	59	15
Prednisone	Prednisone	59	53
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	58	16
Ezetimibe	Ezetimibe	57	16
Glipizide	Glipizide	57	15
Jardiance	Empagliflozin	57	14
Metformin Hcl Er	Metformin Hcl	57	21
Quetiapine Fumarate	Quetiapine Fumarate	57	suppressed
Buspirone Hcl	Buspirone Hcl	55	12
Ozempic	Semaglutide	55	13
Sumatriptan Succinate	Sumatriptan Succinate	54	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	50	11
Aripiprazole	Aripiprazole	48	suppressed
Bumetanide	Bumetanide	48	13
Glimepiride	Glimepiride	48	12
Hydralazine Hcl	Hydralazine Hcl	48	12
Carvedilol	Carvedilol	46	16
Fluticasone Propionate	Fluticasone Propionate	45	17
Mirtazapine	Mirtazapine	44	11
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	42	27
Tramadol Hcl	Tramadol Hcl	40	17
Pregabalin	Pregabalin	39	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	38	suppressed
Allopurinol	Allopurinol	37	12
Citalopram Hbr	Citalopram Hydrobromide	37	suppressed
Azithromycin	Azithromycin	35	32
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	35	11
Pravastatin Sodium	Pravastatin Sodium	35	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	34	26
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	34	11
Synthroid	Levothyroxine Sodium	33	suppressed
Methylprednisolone	Methylprednisolone	32	27
Alendronate Sodium	Alendronate Sodium	31	suppressed
Amoxicillin	Amoxicillin	31	17
Chlorthalidone	Chlorthalidone	30	11
Advair Hfa	Fluticasone Propion/Salmeterol	29	suppressed
Bupropion Xl	Bupropion Hcl	29	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	29	suppressed
Trulicity	Dulaglutide	29	suppressed
Diclofenac Sodium	Diclofenac Sodium	28	11
Glipizide Er	Glipizide	28	suppressed
Ibuprofen	Ibuprofen	28	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	27	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	27	suppressed
Nitroglycerin	Nitroglycerin	27	11
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	27	suppressed
Vitamin D2	Ergocalciferol (Vitamin D2)	27	suppressed
Warfarin Sodium	Warfarin Sodium	27	suppressed
Fluconazole	Fluconazole	26	16
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	26	suppressed
Januvia	Sitagliptin Phosphate	25	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	25	11
Olmesartan Medoxomil	Olmesartan Medoxomil	25	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	24	suppressed
Atenolol	Atenolol	24	suppressed
Ropinirole Hcl	Ropinirole Hcl	24	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	24	suppressed
Cephalexin	Cephalexin	23	18
Naproxen	Naproxen	23	suppressed
Sucralfate	Sucralfate	22	suppressed
Breo Ellipta	Fluticasone/Vilanterol	21	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	21	suppressed
Baclofen	Baclofen	20	suppressed
Nystatin	Nystatin	20	13
Xarelto	Rivaroxaban	20	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	19	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	19	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	19	suppressed
Ramipril	Ramipril	19	suppressed
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	17	suppressed
Oxycodone Hcl	Oxycodone Hcl	17	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	16	suppressed
Jantoven	Warfarin Sodium	16	suppressed
Mounjaro	Tirzepatide	16	suppressed
Tradjenta	Linagliptin	16	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	15	15
Benazepril Hcl	Benazepril Hcl	15	suppressed
Memantine Hcl	Memantine Hcl	15	suppressed
Promethazine Hcl	Promethazine Hcl	15	suppressed
Incruse Ellipta	Umeclidinium Bromide	14	suppressed
Ondansetron Hcl	Ondansetron Hcl	14	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	14	12
Verapamil Er	Verapamil Hcl	14	suppressed
Clonazepam	Clonazepam	13	suppressed
Fenofibrate	Fenofibrate	13	suppressed
Fenofibrate	Fenofibrate,micronized	13	suppressed
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	13	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	13	suppressed
Lovastatin	Lovastatin	13	suppressed
Spironolactone	Spironolactone	13	suppressed
Trintellix	Vortioxetine Hydrobromide	13	suppressed
Valacyclovir	Valacyclovir Hcl	13	suppressed
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	12	suppressed
Dulera	Mometasone/Formoterol	12	suppressed
Enalapril Maleate	Enalapril Maleate	12	suppressed
Lamotrigine	Lamotrigine	12	suppressed
Linzess	Linaclotide	12	suppressed
Midodrine Hcl	Midodrine Hcl	12	suppressed
Piroxicam	Piroxicam	12	suppressed
Rybelsus	Semaglutide	12	suppressed
Topiramate	Topiramate	12	suppressed
Varenicline Tartrate	Varenicline Tartrate	12	suppressed
Memantine Hcl Er	Memantine Hcl	11	suppressed
Nyamyc	Nystatin	11	suppressed
Ondansetron Odt	Ondansetron	11	suppressed
Paroxetine Hcl	Paroxetine Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error